Enter to open, tab to navigate, enter to select
Celldex Therapeutics, Inc. and Kolltan Pharmaceuticals, Inc. merger
| November 01, 2016 • Private Acquisition Agreements • $62.5 million (subject to purchase price adjustment and additional earn-out payment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.